Introduction to Dyslipidemias Drugs used for dyslipidemias or Antihyperlipidemic drugs play a critical role in managing lipid disorders, which are significant risk factors for cardiovascular diseases such as coronary heart disease (CHD). Over 650,000 people die of CHD in the US alone every year, and a 1% reduction in serum cholesterol has been associated with … Read more
Phosphodiesterase type 5 (PDE5) inhibitors are first‑line oral agents for erectile dysfunction that augment the endogenous nitric oxide–cGMP pathway in the corpus cavernosum to facilitate erection with sexual stimulation, and the class includes sildenafil, vardenafil, tadalafil, and avanafil. Standard pharmacology texts detail shared mechanisms with clinically important differences in onset, duration, food effects, selectivity, and … Read more